Ovulation suppression following subcutaneous administration of depot medroxyprogesterone acetate

Objectives: To characterize the relationship between serum medroxyprogesterone acetate (MPA) concentrations and ovulation suppression, and to estimate the risk of ovulation for investigational subcutaneous regimens of Depo-Provera CI (Depo-Provera) and Depo-subQ Provera 104 (Depo-subQ). Study Design...

Full description

Bibliographic Details

Published in:	Contraception: X
Main Authors:	Douglas J. Taylor, Vera Halpern, Vivian Brache, Luis Bahamondes, Jeffrey T. Jensen, Laneta J. Dorflinger
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Subjects:	DMPA Depo-Provera Depo-subQ Provera Pharmacokinetics Pharmacodynamics
Online Access:	http://www.sciencedirect.com/science/article/pii/S2590151622000028